Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 3.770
+0.070 (1.89%)
Aug 1, 2025, 3:58 PM CET
Vista Outdoor Revenue
In the year 2024, Arctic Bioscience AS had annual revenue of 44.40M NOK with 31.55% growth. Arctic Bioscience AS had revenue of 27.20M in the half year ending December 31, 2024, with 35.54% growth.
Revenue
44.40M
Revenue Growth
+31.55%
P/S Ratio
2.28
Revenue / Employee
2.02M
Employees
22
Market Cap
101.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.40M | 10.65M | 31.55% |
| Dec 31, 2023 | 33.76M | -713.30K | -2.07% |
| Dec 31, 2022 | 34.47M | 12.95M | 60.21% |
| Dec 31, 2021 | 21.52M | 922.35K | 4.48% |
| Dec 31, 2020 | 20.59M | -9.45M | -31.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 603.92M |
| Nordhealth AS | 545.88M |
| Photocure ASA | 532.69M |
| Vistin Pharma ASA | 440.66M |
| Omda AS | 442.14M |
| ArcticZymes Technologies ASA | 102.97M |
| Gentian Diagnostics ASA | 163.38M |
| Lytix Biopharma AS | 608.00K |